PREFERRED STOCK	12 Months Ended
Dec. 31, 2021
Equity [Abstract]
PREFERRED STOCK	NOTE 5 – PREFERRED STOCK On October 10, 2021, the Company amended its Article of Incorporation, creating and designating 10,000,000 shares of Series A preferred stock, par value $0.001. Each share of Convertible Series A Preferred Stock is convertible into 1,000 shares of common stock. In addition, the Convertible Series A Preferred Stock has voting privileges of 1,000 votes for each share held. Our sole officer and director holds 100% of the Convertible Series A Preferred Stock. Refer to Note 6 for shares issued to a related party.

PREFERRED STOCK

12 Months Ended

Dec. 31, 2021

NOTE 5 – PREFERRED STOCK

On October 10, 2021, the Company amended its Article of Incorporation, creating and designating 10,000,000 shares of Series A preferred stock, par value $0.001.

Each share of Convertible Series A Preferred Stock is convertible into 1,000 shares of common stock. In addition, the Convertible Series A Preferred Stock has voting privileges of 1,000 votes for each share held.

Our sole officer and director holds 100% of the Convertible Series A Preferred Stock.

Refer to Note 6 for shares issued to a related party.

NUONCOLOGY LABS INC 10-K/A